Logo

Prosolia

With Purchase of Prosolia Tech, Waters Continues Building Direct Ionization Mass Spec Portfolio
Premium

Waters said the acquisition is part of a strategy to develop simpler, more streamlined mass spec workflows that will be accessible to non-expert users.

Waters Acquires Rights to Prosolia DESI Technology for Mass Spec

As part of the deal, Waters has also placed a Synapt G2-Si mass spec instrument at Purdue University to help advance research applications for DESI.

Thermo Fisher Registers HPLC as FDA Class I Medical Device; Inks Reseller Deal with Prosolia

The company registered its Prelude LX-4 MD HPLC as a Class I medical device for general clinical use. 

MALDI, Other Surface Sampling Methods Continue to Make Inroads in Clinical, Quantitative Proteomics
Premium

While LC-MS/MS workflows using triple quadrupoles and, more recently, Q-TOF and Q-Exactive instruments, have typically dominated discussion of mass spec-based protein quantitation, MALDI mass spec has recently emerged as a potential alternative for such applications.

Prosolia Licenses Sample Introduction Technologies from AB Sciex

NEW YORK (GenomeWeb News) – AB Sciex has licensed to Prosolia a portfolio of new sample introduction and ionization methods based on a liquid microjunction surface sampling approach.
Breaking News
The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.